Toru Hifumi to Neuroleptic Malignant Syndrome
This is a "connection" page, showing publications Toru Hifumi has written about Neuroleptic Malignant Syndrome.
Connection Strength
0.606
-
The authors' response: Propofol in COVID 19: From basic science to clinical impact. Am J Emerg Med. 2021 07; 45:528.
Score: 0.203
-
The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome. Am J Emerg Med. 2021 05; 43:274.
Score: 0.202
-
Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med. 2020 10; 38(10):2243.e1-2243.e3.
Score: 0.201